{"id":128024,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2025-04-10","captureTimestamp":"2025-04-10T11:19:36.792000+00:00","jobId":2,"originalUrl":"https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true","snippet":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis:A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) - CIHR Skip to main content Skip to \"About this site\" Canada.ca Services Departments Language selection Français Search…","rawSnapshotUrl":"/api/snapshots/raw/128024","browseUrl":"https://replay.healtharchive.ca/job-2/20250410111936/https://cihr-irsc.gc.ca/e/54083.html?wbdisable=true#ha_snapshot=128024","mimeType":"text/html","statusCode":200}